The survival of all glioma patients with PTPμ high and PTPμ low is plotted either unadjusted (Figure 2a) or adjusted (Figure 2b) by gender, grade, age group, and IDH1 mutation status. The gene discussed is IDH1; the disease is central nervous system cancer.